GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective ...

All cells, whether big or small, short or long, rely on proteins to function properly. In most cells, transporting these ...

Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other ...

GLP-1 RA use is associated with a lower risk of developing Parkinson disease compared with sulfonylurea use in a large cohort study.

The human P2X4 receptor plays an important role in chronic pain, inflammation and some types of cancer. Researchers at the University of Bonn and the University Hospital Bonn (UKB) have now discovered ...

Key opportunities in the GLP-1 receptor agonist market include leveraging increased type 2 diabetes prevalence, expanding ...

Folate receptor alpha (FRα) is a promising target for therapies against certain cancers, especially ovarian cancer and lung adenocarcinoma. Market opportunities are driven by innovative ADCs, small ...

Serotonin receptor agonists are a group of medications that activate the serotonin receptors in the central nervous system. A low serotonin level can lead to difficulty sleeping, depression, anxiety, ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

Details and references regarding individual diseases are provided in the Supplementary Appendix. CIDP denotes chronic inflammatory demyelinating polyneuropathy, Covid-19 coronavirus disease 2019, and ...